All
Results: 1117-1128 of 48808

Takeda Announces Positive Results from Two Pivotal Phase 3 Studies of Oveporexton (TAK-861) in Narcolepsy Type 1

ROYC and Partners Financial Group Announce Strategic Partnership to Deliver Private Markets Investment Solutions Across Central and Eastern Europe

New independent analysis reveals significant business benefits of implementing DeepSights by Market Logic
